BackQuantum BioPharma Overview

Quantum BioPharma Receivables

Quantum BioPharma's receivables is $210K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$209209.00
↓ 93.87% YoYΔ $-3.20M vs prior year quarter

Peer average

Loading

Quantum BioPharma Receivables History

Loading

Quantum BioPharma vs. peers: Receivables Comparison

Loading

Quantum BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Quantum BioPharma (QNTM) FAQ

Quantum BioPharma (QNTM) currently reports a receivables of $210K as of March 2026. That compares with $3.4M in the prior-year period — down 93.9% year over year. Use the charts on this page to explore Quantum BioPharma's receivables history and peer comparisons.

Quantum BioPharma's receivables decreased from $3.4M to $210K — a 93.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Quantum BioPharma reported $210K in receivables as of March 2026. That compares with $3.4M in the prior-year period — down 93.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $210K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quantum BioPharma, and consider following QNTM for alerts when major investors trade the stock.